Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation

By Thomas A.G.   Olkowski J.L.   Slusher B.S.  

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 35-38

Elsevier

Access to resources Recommend Favorite

Competitive Gly/NMDA Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 809-821

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational NMDA receptor modulators for depression

By Szewczyk Bernadeta   Pałłucha-Poniewiera Agnieszka   Poleszak Ewa   Pilc Andrzej   Nowak Gabriel  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 91-102

Informa Healthcare

Access to resources Recommend Favorite

Novel NMDA receptor modulators: an update

By Santangelo Rose M   Acker Timothy M   Zimmerman Sommer S   Katzman Brooke M   Strong Katie L   Traynelis Stephen F   Liotta Dennis C  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1337-1352

Informa Healthcare

Access to resources Recommend Favorite

Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice

By Czuczwar S.J.   Borowicz K.K.   Kleinrok Z.   Tutka P.   Zarnowski T.   Turski W.A.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 327-333

Elsevier

Access to resources Recommend Favorite